JLA: Journal of Lipid and Atherosclerosis
JLA: Journal of Lipid and Atherosclerosis
  • 98
  • 13 402

Video

Clinical Characteristics of Patients With Statin Discontinuation in Korea
zhlédnutí 22Před 3 měsíci
J Lipid Atheroscler. 2024 Jan;13(1):41-52. English. Published online Nov 28, 2023. You can read this article at doi.org/10.12997/jla.2024.13.1.41 #JLA #lipid #atherosclerosis
SR-BI Deficiency in Mice Is Associated With Plasma Ceramide and Sphingomyelin Accumulation
zhlédnutí 17Před 3 měsíci
J Lipid Atheroscler. 2024 Jan;13(1):69-79. English. Published online Nov 06, 2023. You can read this article at doi.org/10.12997/jla.2024.13.1.69 #JLA #lipid #atherosclerosis
Statins Ticagrelor and Rhabdomyolysis: A Coincidence or a Drug Interaction?
zhlédnutí 39Před 3 měsíci
J Lipid Atheroscler. 2024 Jan;13(1):61-68. English. Published online Oct 26, 2023. You can read this article at doi.org/10.12997/jla.2024.13.1.61 #JLA #lipid #atherosclerosis
Putative Pathogenic Variants of ABCG5 and ABCG8 of Sitosterolemia in Patients With Hyper LDL-C
zhlédnutí 43Před 3 měsíci
J Lipid Atheroscler. 2024 Jan;13(1):53-60. English. Published online Oct 04, 2023. You can read this article at doi.org/10.12997/jla.2024.13.1.53 #JLA #lipid #atherosclerosis
The partner with the Korean Society of Lipids and Atherosclerosis (KSoLA)
zhlédnutí 18Před 3 měsíci
The partner with the Korean Society of Lipids and Atherosclerosis (KSoLA)
Association of Clinical Characteristics With Familial Hypercholesterolaemia Variants
zhlédnutí 22Před 3 měsíci
J Lipid Atheroscler. 2024 Jan;13(1):29-40. English. Published online Oct 26, 2023. You can read this article at doi.org/10.12997/jla.2024.13.1.29 #JLA #lipid #atherosclerosis
The Role of COVID 19 Vaccination for Patients With ASCVD in the Upcoming Endemic Era
zhlédnutí 11Před 3 měsíci
J Lipid Atheroscler. 2024 Jan;13(1):21-28. English. Published online Jan 23, 2024. You can read this article at doi.org/10.12997/jla.2024.13.1.21 #JLA #lipid #atherosclerosis
Advances in Dyslipidaemia Treatments Focusing on ApoC3 and ANGPTL3 Inhibitors
zhlédnutí 109Před 3 měsíci
J Lipid Atheroscler. 2024 Jan;13(1):2-20. English. Published online Oct 27, 2023. You can read this article at doi.org/10.12997/jla.2024.13.1.2 #JLA #lipid #atherosclerosis
Profiling of RNA-binding Proteins Interacting With Glucagon and Adipokinetic Hormone mRNAs
zhlédnutí 38Před 6 měsíci
J Lipid Atheroscler. 2022 Jan;11(1):55-72. English. Published online Jul 29, 2021. You can read this article at doi.org/10.12997/jla.2022.11.1.55 #JLA #lipid #atherosclerosis
Dietary Oxidized Linoleic Acids Modulate Fatty Acids in Mice
zhlédnutí 22Před 6 měsíci
J Lipid Atheroscler. 2022 May;11(2):197-210. English. Published online Apr 29, 2022. You can read this article at doi.org/10.12997/jla.2022.11.2.197 #JLA #lipid #atherosclerosis
2024년도 한국지질·동맥경화학회와 함께 하세요.
zhlédnutí 129Před 6 měsíci
2024년도 한국지질·동맥경화학회와 함께 하세요.
Triglyceride-Glucose Index Is a Useful Marker for Predicting Future CVD and Mortality
zhlédnutí 158Před 6 měsíci
J Lipid Atheroscler. 2022 May;11(2):178-186. English. Published online Apr 21, 2022. You can read this article at doi.org/10.12997/jla.2022.11.2.178 #JLA #lipid #atherosclerosis
Effects of Short Term Adiponectin Receptor Agonism on Cardiac Function and Energetics
zhlédnutí 19Před 6 měsíci
J Lipid Atheroscler. 2022 May;11(2):161-177. English. Published online Mar 31, 2022. You can read this article at doi.org/10.12997/jla.2022.11.2.161 #JLA #lipid #atherosclerosis
NAD+ and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities
zhlédnutí 36Před 6 měsíci
J Lipid Atheroscler. 2022 May;11(2):111-132. English. Published online Apr 06, 2022. You can read this article at doi.org/10.12997/jla.2022.11.2.111 #JLA #lipid #atherosclerosis
Understanding and Utilizing Claim Data from the NHIS and HIRA Database for Research
zhlédnutí 23Před 6 měsíci
Understanding and Utilizing Claim Data from the NHIS and HIRA Database for Research
Impact of Severe Hypercholesterolemia on Cardiovascular Risk in Individuals With or Without Diabetes
zhlédnutí 38Před 6 měsíci
Impact of Severe Hypercholesterolemia on Cardiovascular Risk in Individuals With or Without Diabetes
Shinjulactone A Blocks Vascular Inflammation and the Endothelial-Mesenchymal Transition
zhlédnutí 39Před 7 měsíci
Shinjulactone A Blocks Vascular Inflammation and the Endothelial-Mesenchymal Transition
Vegetarian Diet for Cardiovascular Disease Risk Reduction: Cons
zhlédnutí 17Před 7 měsíci
Vegetarian Diet for Cardiovascular Disease Risk Reduction: Cons
Vegetarian Diets and Cardiovascular Risk Reduction: Pros
zhlédnutí 12Před 7 měsíci
Vegetarian Diets and Cardiovascular Risk Reduction: Pros
The Cardiovascular Effect of Tirzepatide
zhlédnutí 37Před 7 měsíci
The Cardiovascular Effect of Tirzepatide
Public Awareness of Dyslipidemia among the Korean Population: A Survey Study
zhlédnutí 30Před 7 měsíci
Public Awareness of Dyslipidemia among the Korean Population: A Survey Study
Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway
zhlédnutí 48Před 7 měsíci
Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway
Mechanisms of the Wnt Pathways in Atherogenesis and Its Potential as a Target
zhlédnutí 42Před 7 měsíci
Mechanisms of the Wnt Pathways in Atherogenesis and Its Potential as a Target
Lipid-Lowering Efficacy of Combination Therapy Versus Monotherapy
zhlédnutí 32Před 7 měsíci
Lipid-Lowering Efficacy of Combination Therapy Versus Monotherapy
Elevated Lipoprotein(a) Levels and Atrial Fibrillation: A Systematic Review
zhlédnutí 34Před 7 měsíci
Elevated Lipoprotein(a) Levels and Atrial Fibrillation: A Systematic Review
Dyslipidemia Fact Sheet in South Korea, 2022
zhlédnutí 59Před 7 měsíci
Dyslipidemia Fact Sheet in South Korea, 2022
Assessing the Practical Differences in LDL-C Estimates
zhlédnutí 148Před 7 měsíci
Assessing the Practical Differences in LDL-C Estimates
ICoLA 2023
zhlédnutí 477Před 9 měsíci
ICoLA 2023
Assessing the Validity of the Criteria for the Extreme Risk Category of ASCVD
zhlédnutí 36Před 11 měsíci
Assessing the Validity of the Criteria for the Extreme Risk Category of ASCVD

Komentáře